New diabetes clinical trial: Clinical Trial to Evaluate the Efficacy and Safety of Monotherapy Group of HL1113R1 or HL1113R2 Versus HL1113 (Fixed Dose Combination) in Patients With Essential Hypertension and Type II Diabetes Mellitus

Published on: 2026-04-27T04:00:00Z
Conditions: Hypertension; Diabete Type 2
Interventions: Drug: Test group; Drug: Exploratory test group; Drug: Control group 1; Drug: Control group 2
Sponsors: Hanlim Pharm. Co., Ltd.
Recruiting
https://ift.tt/BbEjhs6